Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 28 of 1,261
  1. US 12365723

    Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  2. US 12365728

    DLL3 single domain antibodies and therapeutic compositions thereof

    Inhibrx Biosciences, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  3. US 12364661

    Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery

    The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  4. US 12365729

    Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis

    Disc Medicine, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  5. US 12365887

    CRISPR-Cas effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  6. US 12365889

    Tunable nanoscale cages from self-assembling DNA and protein building blocks

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  7. US 12365897

    RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereof, and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  8. US 12364717

    Compositions and methods for inhibiting seizures

    The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  9. US 12364736

    Methods for treating heterotopic ossification

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  10. AR 132581

    COMPOSICIÓN INMUNÓGENA ÚTIL PARA LA AUTOADMINISTRACIÓN POR CERDOS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Jul 16, 2025 · Expires Jul 11, 2045

    granted
  11. US 12357650

    Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation

    Shuttle Pharmaceuticals, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  12. US 12357598

    Treatment of neurodevelopmental disorders

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  13. US 12357580

    Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids

    The Board of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  14. US 12358971

    Arena virus monoclonal antibodies and uses

    The Boad of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  15. US 12357623

    Method for treating a disease or condition using a pyrazole compound or formulation thereof

    Rigel Pharmaceuticals, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  16. US 12357570

    Chemoembolization agents

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  17. US 12357590

    Binge behavior regulators

    CLEARMIND MEDICINE INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  18. US 12359219

    Transgene cassettes designed to express a human MECP2 gene

    The Board of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  19. US 12357555

    Self-emulsifying composition, intended for administration onto the skin, containing biosurfactant, cosurfactant and oil phase

    INVENTIONBIO SPÓKA Z OGRANICZON ODPOWIEDZIALNOCIA · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  20. US 12358879

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  21. US 12358979

    Antibodies that bind interleukin 13 and methods of use

    Apogee Therapeutics, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  22. US 12357615

    Compositions for the treatment of brain tumors

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  23. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  24. US 12357582

    Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.